Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

BTG gets US rights to Wellstat’s 5-FU antidote

Executive Summary

BTG International Inc., the US division of BTG PLC has licensed exclusive rights to market Wellstat Therapeutics Corp.’s (neurology, metabolic, and oncology) investigational drug uridine triacetate (PN401) in the US for up to ten years.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Royalty or Profit Split Information
    • Marketing (Licensing)

Related Companies